Search Tag: remdesivir

ICU Management

Solidarity-trial-interim-results-antiviral-drugs-in-hospitalised-covid-19-patients

2021 16 Feb

Mortality trials of four antiviral drugs - remdesivir, hydroxychloroquine, lopinavir and interferon beta-1a were recommended by the World Health Organization (WHO) to evaluate their effect in patients hospitalised with COVID-19. In March 2020, the WHO began a large international trial that included hospital inpatients to evaluate the effects...Read more

ICU Management

Treating-early-covid-19-infection

2020 14 Nov

There have been over 47 million cases of COVID-19 globally and 1.2 million deaths. According to Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases (NIAID), the treatment of patients with early COVID-19 infection requires urgent focus. Treating these patients early in the course of infection could help speed up their...Read more

Executive Health Management

Lottery-for-insufficient-drugs-allocation

2020 29 Jun

One solution to the problem of scarce medications allocation, which has been exacerbated by the COVID-19 pandemic, can be the implementation of a centralised lottery system, an article in JAMA argues.   You might also like: EMA Fast-Tracking Procedures for COVID-19 Medicines   The authors (White and Angus 2020) take as an example...Read more

Executive Health Management

Potential-covid-19-treatments-some-in-some-out

2020 27 May

The UK health ministry has announced that the antiviral drug remdesivir would be made available to selected COVID-19 patients while the World Health Organization (WHO) is putting the hydroxychloroquine/chloroquine arm within the COVID-19 Solidarity Trial on hold.   You may also like : From Hydroxychloroquine and Remdesivir to Plasma Administration...Read more

ICU Management

Volume-20-issue-1-2020-1

2020 19 May

Change content default valueRead more

ICU Management

From-hydroxychloroquine-and-remdesivir-to-plasma-administration

2020 19 May

Clinicians are faced with a serious disease with no effective therapy. Several options are being considered to treat COVID-19, but how promising are these drugs? A  number of colleagues and friends from outside the hospital have asked me whether they should take hydroxychloroquine for their COVID-19. A friend asked me whether he should...Read more

Cardiology Management

Remdesivir-in-adults-with-severe-covid-19

2020 06 May

The search for a drug to treat patients with coronavirus disease (COVID-19) has created an interest in a relatively new antiviral drug called remdesivir. Although the majority of patients who acquire coronavirus only develop a self-limited mild illness, around 10-20% of patients develop severe pneumonia and respiratory distress that requires ICU care,...Read more